Charles Owusu Aseku, a patient in Ghana’s first 3D telemedicine trial, has finally healed after a long battle with a keloid scar that began in 2002. He had undergone several unsuccessful surgeries, including in South Africa, but the trial remotely connected him with specialists abroad, ultimately leading to successful treatment.
3D telemedicine was developed by Microsoft in collaboration with Ghanaian doctors. It bridges the gap between African patients and global experts, effectively addressing the shortage of doctors. The use of enhanced lighting and cameras allows for the creation of 3D models, enabling precise remote assessments.
Telemedicine can significantly enhance access to healthcare services in Africa, especially in light of disruptions caused by climate change.
Our take: Nothing can replace the authenticity and confidence of an in-person visit with a doctor. But 3D imaging technology offers a promising alternative for remote telemedicine compared to the current 2D technology… Read more (2 min)
In March, the most visible healthcare venture funding in Africa was directed towards telemedicine companies, highlighting their essential role in climate health adaptation. Each of the four funded companies received undisclosed amounts ranging from $100K to $500K. These companies operate English, French and Arabic.
Egypt benefited from funding for two companies, Chefaa and Weyak, while Eyone in Senegal and Purelife in Nigeria represent West Africa. Notably, East and Southern Africa were absent from this funding wave in March.
Eyone streamlines healthcare in Senegal by utilising digital records, PureLife provides telehealth and pharmacy services in Nigeria, Shifaa ensures prompt medication delivery in Egypt, and Weyak assists chronic illness patients with home consultations and medical discounts.
Our take: The solution is right in front of us. Telehealth has the potential to be a vital lifeline in Africa, connecting patients to doctors through mobile devices via direct calls, SMS, and video calls… Read more (2 min)
African health policies are evolving to address climate challenges. The Harare Declaration, signed by 20 health ministers, emphasises the importance of early warning systems and research to combat diseases driven by climate change. Additionally, 29 countries joined the Alliance for Transformative Action on Climate and Health.
In Nigeria and South Africa, funding reallocations are being implemented to counteract cuts in US aid, ensuring a robust response to epidemics and enhancing healthcare resilience in the face of climate threats.
Sierra Leone’s Heat Action Plan incorporates early warning systems, cooling strategies, and adaptation measures, focusing on vulnerable communities and establishing a link between climate change and health.
Our take: African nations must prioritise climate-health policies that not only reduce emissions but also improve public health. Investing in clean energy, integrating health considerations into climate strategies, and mobilising health experts will accelerate mitigation efforts and facilitate policy change…Read more (2 min)
____________________
Novo Nordisk Middle Africa opens a new, expanded office in Nairobi. Novo Nordisk, a global healthcare company, develops and delivers medicines and delivery systems for serious chronic diseases like diabetes.
Events
🗓️ Attend the 2025 Global Conference on Climate and Health in Brazil (July 29)
🗓️ Register for the 2025 Africa Health Awards and Summit in Cape Verde ( April 25)
🗓️ Join the Kenya Pharma & Healthcare Expo ( April 10)
Jobs
🧑⚕️ Work with Linda Hausermann as a business manager in healthcare (Nigeria)
🧑⚕️ Be the next manager, patient services at Prairie Mountain Health ( Liberia)
Seen on LinkedIn
Wellcome Trust, in their latest report, says, “Fungi can keep us healthy or cause disease. They’re in the air, in the soil and in our bodies. But as the climate changes, fungi are changing too. Some are adapting to rising temperatures and spreading to new geographies, including urban areas. A perfect storm of factors is increasing the threat of fungal disease.”
____________________